LSD1 inhibition attenuates targeted therapy-induced lineage plasticity in BRAF mutant colorectal cancerChristopher A. Ladaika, Heather M. O’Hagan|Molecular Cancer|2025Cited by 4
LSD1 inhibition attenuates targeted therapy-induced lineage plasticity in <i> BRAF <sup>V600E</sup> </i> colorectal cancerChristopher A. Ladaika, Heather M. O’Hagan|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0